Audiomedica.com

Rivaroxaban Confirmed as Oral Alternative For Cancer Thromboembolism

Informações:

Sinopsis

ATLANTA—Six months follow up of the Select-D randomized open label multicenter pilot study with 406 patients has confirmed that therapy with the direct oral anticoagulant (DOAC) rivaroxaban was a safe and effective alternative strategy to standard treatment with the low …180131 Annie Young INTERVIEW PRODUCTION MASTER